Differential Effects of Sunitinib on the Expression Profiles of Xenobiotic‐Metabolizing Enzymes and Transporters in Rat Liver and Kidneys
Sunitinib (SUN) is a multi‐targeted tyrosine kinase inhibitor that was recently approved for the treatment of gastrointestinal tract and renal cancers. To date, very little is known about the effects of SUN on the expression of hepatic and renal xenobiotic‐metabolizing enzymes (XMEs) and transporter...
Gespeichert in:
Veröffentlicht in: | Basic & clinical pharmacology & toxicology 2016-08, Vol.119 (2), p.173-183 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!